medigraphic.com

2006, Number 1

<< Back Next >>

Med Sur 2006; 13 (1)

The response evaluation to FDG-F18 PET-CT treatment in a 40 years-old male with a diagnosis of non-Hodgking T-cell lymphoma

Valdivieso-Cárdenas G, Vega-González I, Rumoroso-García A, Roldán-Valadez E, Morales-Santillán O, Orta-Díaz MD, Aguay-González A

Language: Spanish
References: 11
Page: 12-16
PDF size: 158.22 Kb.


ABSTRACT

This case presents the utility of the PET-CT, FDG-F18 to assessment the therapy response after a 6-dose treatment of chemotherapy in a 40 years-old male with a diagnosis of non-Hodgking T-cell lymphoma of the nasal cavity and nasopharynx by using basal and post-treatment studies. The assessment with PET-CT left no doubts about the extension of the residual disease which has not been well defined using CT alone. In the other hand the PET-CT study can to evaluate the extension disease.


REFERENCES

  1. Fanti S, Franchi R, Battista G, Monetti N, Canini R. PET and PET-CT. State of the art and future prospects. Radiol Med (Torino) 2005; 110: 1-15.

  2. Quraishi MS, Bessell EM, Clark D, Jones NS, Bradley PJ. Non-Hodgkin’s lymphoma of the sinonasal tract. Laryngoscope 2000; 110: 1489-1492.

  3. Ooi GC, Chim CS, Liang R, Tsang KW, Kwong YL. Nasal T-cell/natural killer cell lymphoma: CT and MR imaging features of a new clinicopathologic entity. AJR Am J Roentgenol 2000; 174:

  4. 1141-1145.

  5. Kostakoglu L, Leonard JP, Coleman M, Goldsmith SJ. The Role of FDG-PET Imaging in the Management of Lymphoma. Clin Adv Hematol Oncol 2004; 2: 115-121.

  6. Pagano L, Gallamini A, Trape G et al. NK/T-cell lymphomas ‘nasal type’: an Italian multicentric retrospective survey. Ann Oncol 2006.

  7. Khosravi SP, Diaz Munoz de la Espada VM. [Extranodal T/NKcell lymphoma, nasal type: a case report and review of the literature]. An Med Interna 2005; 22: 597-600.

  8. Batlle JC, Zhuang H, Potenta S, Kumar R, Alavi A. Hodgkin disease in the sinonasal region detected by FDG PET. Clin Nucl Med 2004; 29: 449.

  9. Li YX, Yao B, Jin J et al. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma. J Clin Oncol 2006; 24: 181-189.

  10. Lee J, Kim WS, Park YH et al. Nasal-type NK/T cell lymphoma: clinical features and treatment outcome. Br J Cancer 2005; 92: 1226-1230.

  11. 10.Chander S, Webster GC, Zingas AP et al. American Burkitt’s lymphoma of the head and neck: evaluation with serial FDGPET. Clin Nucl Med 2004; 29: 646-648.




2020     |     www.medigraphic.com